Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
In a groundbreaking study published in Nature, Australian scientists have resolved a long-standing problem in regenerative medicine. Led by Professor Ryan Lister from the Harry Perkins Institute of ...
Human skin cells have been reprogrammed into heart valve cells and then used to successfully transplant a pig heart valve into a rodent, led by the research of a Northeastern University professor. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results